Dow Down 0.03% Nasdaq Down 0.13%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
33.07 Up 0.34(1.05%) 3:02PM EDT - Nasdaq Real Time Price
Prev Close:32.73
Open:32.84
Bid:33.13 x 200
Ask:33.17 x 100
1y Target Est:N/A
Beta:N/A
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:32.35 - 33.22
52wk Range:27.51 - 39.95
Volume:227,372
Avg Vol (3m):556,225
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORUp 1.05%1.36B
BIIBDown 0.19%80.84B
TEVADown 0.08%44.55B

Key Statistics

Forward P/E (1 yr):56.17
P/S (ttm):3.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.22
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):9.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback